These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15138129)

  • 1. Correlation of glycosyltransferases mRNA expression in extrahepatic bile duct carcinoma with clinical pathological characteristics.
    Jin XL; Zheng SS; Wang BS; Chen HL
    Hepatobiliary Pancreat Dis Int; 2004 May; 3(2):292-5. PubMed ID: 15138129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration in N -acetylglucosaminyltransferase activities and glycan structure in tissue and bile glycoproteins from extrahepatic bile duct carcinoma.
    Jin XL; Liu HB; Zhang Y; Wang BS; Chen HL
    Glycoconj J; 2004; 20(6):399-406. PubMed ID: 15238704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caveolin-I overexpression is a favourable prognostic factor for patients with extrahepatic bile duct carcinoma.
    Murakami S; Miyamoto M; Hida Y; Cho Y; Fukunaga A; Oshikiri T; Kato K; Kurokawa T; Suzuoki M; Nakakubo Y; Hiraoka K; Itoh T; Shinohara T; Morikawa T; Okushiba O; Kondo S; Katoh H
    Br J Cancer; 2003 Apr; 88(8):1234-8. PubMed ID: 12737162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fascin expression is correlated with tumor progression of extrahepatic bile duct cancer.
    Okada K; Shimura T; Asakawa K; Hashimoto S; Mochida Y; Suehiro T; Kuwano H
    Hepatogastroenterology; 2007; 54(73):17-21. PubMed ID: 17419223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of fascin expression in extrahepatic bile duct carcinomas.
    Won KY; Kim GY; Lim SJ; Park YK; Kim YW
    Pathol Res Pract; 2009; 205(11):742-8. PubMed ID: 19556073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary tumor/vessel tumor/nodal tumor classification of extrahepatic bile duct carcinoma.
    Hasebe T; Konishi M; Iwasaki M; Nakagohri T; Takahashi S; Gotohda N; Kinoshita T; Ochiai A
    Hum Pathol; 2008 Jan; 39(1):37-48. PubMed ID: 17900657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered mRNA expressions of sialyltransferases in ovarian cancers.
    Wang PH; Lee WL; Juang CM; Yang YH; Lo WH; Lai CR; Hsieh SL; Yuan CC
    Gynecol Oncol; 2005 Dec; 99(3):631-9. PubMed ID: 16112178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early detection of extrahepatic bile-duct carcinomas in the nonicteric stage by using MRCP followed by EUS.
    Sai JK; Suyama M; Kubokawa Y; Watanabe S; Maehara T
    Gastrointest Endosc; 2009 Jul; 70(1):29-36. PubMed ID: 19286177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biliary carcinoma risk in patients with pancreaticobiliary maljunction and the degree of extrahepatic bile duct dilatation.
    Kamisawa T; Tu Y; Kuwata G; Egawa N; Nakajima H; Tsuruta K; Okamoto A; Matsukawa M
    Hepatogastroenterology; 2006; 53(72):816-8. PubMed ID: 17153430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological assessment and quantitative estimation of the matrix metalloproteinases MMP-2 and MMP-7 and the inhibitors TIMP-1 and TIMP-2 in colorectal carcinoma tissue samples.
    Pesta M; Topolcan O; Holubec L; Rupert K; Cerna M; Holubec LS; Treska V; Finek J; Cerny R
    Anticancer Res; 2007; 27(4A):1863-7. PubMed ID: 17649785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of c-erbB-2 proto-oncogene in extrahepatic cholangiocarcinoma and its clinical significance.
    Zheng J; Zhu YM
    Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):412-5. PubMed ID: 17690040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and pathological features of primary carcinoma of the cystic duct.
    Nakata T; Kobayashi A; Miwa S; Soeda J; Uehara T; Miyagawa S
    J Hepatobiliary Pancreat Surg; 2009; 16(1):75-82. PubMed ID: 19096752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of extrahepatic bile duct carcinomas according to the New American Joint Committee on Cancer staging system focused on tumor classification problems in 222 patients.
    Hong SM; Kim MJ; Pi DY; Jo D; Cho HJ; Yu E; Ro JY
    Cancer; 2005 Aug; 104(4):802-10. PubMed ID: 15959914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns and relevant factors of tumor recurrence for extrahepatic bile duct carcinoma after radical resection.
    Park SW; Park YS; Chung JB; Kang JK; Kim KS; Choi JS; Lee WJ; Kim BR; Song SY
    Hepatogastroenterology; 2004; 51(60):1612-8. PubMed ID: 15532789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma.
    Tamada S; Shibahara H; Higashi M; Goto M; Batra SK; Imai K; Yonezawa S
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4257-64. PubMed ID: 16857800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of LAPTM4B-35: a novel marker of progression, invasiveness and poor prognosis of extrahepatic cholangiocarcinoma.
    Zhou L; He XD; Cui QC; Zhou WX; Qu Q; Zhou RL; Rui JA; Yu JC
    Cancer Lett; 2008 Jun; 264(2):209-17. PubMed ID: 18334282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term results of 84 surgically treated patients with extrahepatic bile duct carcinoma].
    Zheng SS; Qin YS; Liang TB; Huang DS; Zhang M; Wang WL; Shen Y; Wang JH
    Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):554-6. PubMed ID: 16438856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In situ nucleic acid detection of HBV X gene in extrahepatic biliary tract carcinomas and its clinicopathological significance].
    Qu ZL; Zou SQ; Wei GH; Sun ZC; Wu XZ
    Zhonghua Wai Ke Za Zhi; 2004 Jan; 42(2):88-91. PubMed ID: 15009988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoembryonic antigen messenger RNA expression using nested reverse transcription-PCR in the peripheral blood during follow-up period of patients who underwent curative surgery for biliary-pancreatic cancer: longitudinal analyses.
    Mataki Y; Takao S; Maemura K; Mori S; Shinchi H; Natsugoe S; Aikou T
    Clin Cancer Res; 2004 Jun; 10(11):3807-14. PubMed ID: 15173089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human telomerase reverse transcriptase expression and its clinical significance in laryngeal squamous cell carcinoma.
    Li YR; Wu JM; Wang L; Huang X; Shi J; Hu LH
    Acta Otolaryngol; 2005 Apr; 125(4):409-14. PubMed ID: 15823813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.